'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival

D. R. Saban, S. K. Chauhan, X. Zhang, Jaafar El-Annan, Y. Jin, R. Dana

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Certain components of a graft that provoke alloimmunity may not be vital for graft function or critical as targets of rejection. Corneal transplantation is an example of this, because graft epithelium plays a role in allosensitization, whereas corneal graft endothelium - which shares the same alloantigens - is the critical target in allorejection. In this study, we found that exploiting this biology by replacing donor epithelium of an allograft with an allodisparate third-party epithelium yields a marked enhancement in transplant survival. Such 'chimeric' allografts consisted of a C3H/He (H-2 k) corneal epithelium over a C57BL/6 (H-2 b) epithelial-denuded cornea (or v.v.) and orthotopically placed on BALB/c (H-2 d) hosts. Conventional corneal allografts (C3H/He or C57BL/6) or isografts (BALB/c) were also transplanted on BALB/c hosts. Alloreactive T-cell frequencies (CD4 + interferon [IFN]-γ +) primed to the graft endothelium were strongly diminished in chimeric hosts relative to conventionally allografted hosts. This was corroborated by a decreased T-cell infiltration (p = 0.03) and a marked enhancement of allograft survival (p = 0.001). Our results represent the first successful demonstration of chimeric tissue, epithelial-denuded allograft plus third-party allodisparate epithelium, in the promotion of allograft survival. Moreover, chimeric grafting can be readily performed clinically, whereby corneal allograft rejection remains a significant problem particularly in inflamed graft beds.

Original languageEnglish (US)
Pages (from-to)473-482
Number of pages10
JournalAmerican Journal of Transplantation
Volume9
Issue number3
DOIs
StatePublished - Mar 2009
Externally publishedYes

Fingerprint

Allografts
Transplants
Epithelium
Isografts
T-Lymphocytes
Corneal Endothelium
Corneal Epithelium
Corneal Transplantation
Isoantigens
Cornea
Interferons
Endothelium

Keywords

  • Allograft rejection
  • Allosensitization
  • Corneal allograft
  • Immune regulation
  • Th1
  • Tolerance

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival. / Saban, D. R.; Chauhan, S. K.; Zhang, X.; El-Annan, Jaafar; Jin, Y.; Dana, R.

In: American Journal of Transplantation, Vol. 9, No. 3, 03.2009, p. 473-482.

Research output: Contribution to journalArticle

Saban, D. R. ; Chauhan, S. K. ; Zhang, X. ; El-Annan, Jaafar ; Jin, Y. ; Dana, R. / 'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival. In: American Journal of Transplantation. 2009 ; Vol. 9, No. 3. pp. 473-482.
@article{0302d90f41934dae89ceec4e4754f2f9,
title = "'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival",
abstract = "Certain components of a graft that provoke alloimmunity may not be vital for graft function or critical as targets of rejection. Corneal transplantation is an example of this, because graft epithelium plays a role in allosensitization, whereas corneal graft endothelium - which shares the same alloantigens - is the critical target in allorejection. In this study, we found that exploiting this biology by replacing donor epithelium of an allograft with an allodisparate third-party epithelium yields a marked enhancement in transplant survival. Such 'chimeric' allografts consisted of a C3H/He (H-2 k) corneal epithelium over a C57BL/6 (H-2 b) epithelial-denuded cornea (or v.v.) and orthotopically placed on BALB/c (H-2 d) hosts. Conventional corneal allografts (C3H/He or C57BL/6) or isografts (BALB/c) were also transplanted on BALB/c hosts. Alloreactive T-cell frequencies (CD4 + interferon [IFN]-γ +) primed to the graft endothelium were strongly diminished in chimeric hosts relative to conventionally allografted hosts. This was corroborated by a decreased T-cell infiltration (p = 0.03) and a marked enhancement of allograft survival (p = 0.001). Our results represent the first successful demonstration of chimeric tissue, epithelial-denuded allograft plus third-party allodisparate epithelium, in the promotion of allograft survival. Moreover, chimeric grafting can be readily performed clinically, whereby corneal allograft rejection remains a significant problem particularly in inflamed graft beds.",
keywords = "Allograft rejection, Allosensitization, Corneal allograft, Immune regulation, Th1, Tolerance",
author = "Saban, {D. R.} and Chauhan, {S. K.} and X. Zhang and Jaafar El-Annan and Y. Jin and R. Dana",
year = "2009",
month = "3",
doi = "10.1111/j.1600-6143.2008.02535.x",
language = "English (US)",
volume = "9",
pages = "473--482",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - 'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival

AU - Saban, D. R.

AU - Chauhan, S. K.

AU - Zhang, X.

AU - El-Annan, Jaafar

AU - Jin, Y.

AU - Dana, R.

PY - 2009/3

Y1 - 2009/3

N2 - Certain components of a graft that provoke alloimmunity may not be vital for graft function or critical as targets of rejection. Corneal transplantation is an example of this, because graft epithelium plays a role in allosensitization, whereas corneal graft endothelium - which shares the same alloantigens - is the critical target in allorejection. In this study, we found that exploiting this biology by replacing donor epithelium of an allograft with an allodisparate third-party epithelium yields a marked enhancement in transplant survival. Such 'chimeric' allografts consisted of a C3H/He (H-2 k) corneal epithelium over a C57BL/6 (H-2 b) epithelial-denuded cornea (or v.v.) and orthotopically placed on BALB/c (H-2 d) hosts. Conventional corneal allografts (C3H/He or C57BL/6) or isografts (BALB/c) were also transplanted on BALB/c hosts. Alloreactive T-cell frequencies (CD4 + interferon [IFN]-γ +) primed to the graft endothelium were strongly diminished in chimeric hosts relative to conventionally allografted hosts. This was corroborated by a decreased T-cell infiltration (p = 0.03) and a marked enhancement of allograft survival (p = 0.001). Our results represent the first successful demonstration of chimeric tissue, epithelial-denuded allograft plus third-party allodisparate epithelium, in the promotion of allograft survival. Moreover, chimeric grafting can be readily performed clinically, whereby corneal allograft rejection remains a significant problem particularly in inflamed graft beds.

AB - Certain components of a graft that provoke alloimmunity may not be vital for graft function or critical as targets of rejection. Corneal transplantation is an example of this, because graft epithelium plays a role in allosensitization, whereas corneal graft endothelium - which shares the same alloantigens - is the critical target in allorejection. In this study, we found that exploiting this biology by replacing donor epithelium of an allograft with an allodisparate third-party epithelium yields a marked enhancement in transplant survival. Such 'chimeric' allografts consisted of a C3H/He (H-2 k) corneal epithelium over a C57BL/6 (H-2 b) epithelial-denuded cornea (or v.v.) and orthotopically placed on BALB/c (H-2 d) hosts. Conventional corneal allografts (C3H/He or C57BL/6) or isografts (BALB/c) were also transplanted on BALB/c hosts. Alloreactive T-cell frequencies (CD4 + interferon [IFN]-γ +) primed to the graft endothelium were strongly diminished in chimeric hosts relative to conventionally allografted hosts. This was corroborated by a decreased T-cell infiltration (p = 0.03) and a marked enhancement of allograft survival (p = 0.001). Our results represent the first successful demonstration of chimeric tissue, epithelial-denuded allograft plus third-party allodisparate epithelium, in the promotion of allograft survival. Moreover, chimeric grafting can be readily performed clinically, whereby corneal allograft rejection remains a significant problem particularly in inflamed graft beds.

KW - Allograft rejection

KW - Allosensitization

KW - Corneal allograft

KW - Immune regulation

KW - Th1

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=60649095906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60649095906&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2008.02535.x

DO - 10.1111/j.1600-6143.2008.02535.x

M3 - Article

C2 - 19260831

AN - SCOPUS:60649095906

VL - 9

SP - 473

EP - 482

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 3

ER -